Daiichi Sankyo

China - ShanghaiBiotechnology1 H-1B visas (FY2023)

Focus: Daiichi Sankyo is a public biotechnology company headquartered in Shanghai, specializing in small-molecule oncology, cardiovascular, and metabolic disease therapeutics. The company operates at scale with significant market presence anchored by blockbuster ADC franchises.

Oncology Cardiovascular Metabolic Diseases Neurology

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Daiichi Sankyo

AI assessmentNot Hiring

No open roles listed right now. Follow Daiichi Sankyo to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

1 imminent

SAVAYSA

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

ENHERTU

Breast cancer, gastric cancer, non-small cell lung cancer

$10M Part D

Peak

Blockbuster ADC generating 55% of company revenue with expanding multi-indication franchise and strong clinical momentum in solid tumors.

Help build intelligence for Daiichi Sankyo

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Bempedoic acid and/or its fixed dose combination with ezetimibe

Primary Hypercholesterolemia

N/A

Clinical Trials (1)

NCT05798390Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia

N/A

Edoxaban

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02944019Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation

N/A

Edoxaban

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT04594915Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in Turkey

N/A

Computer Electronic Alert

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02339493Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

N/A

Edoxaban

Heart Failure

N/A

Clinical Trials (1)

NCT02448901Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

N/A

data collection

Metastatic Non-small Cell Lung Cancer (NSCLC)

N/A

Observation

Cardioembolic Stroke

N/A

Clinical Trials (2)

NCT05486351Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

N/A

NCT01496885Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke

No drug

Advanced/Metastatic HER2-negative Breast Cancer

N/A

Clinical Trials (2)

NCT06585501A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

N/A

NCT06975371Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Edoxaban

Non-valvular Atrial Fibrillation

N/A

Clinical Trials (1)

NCT04747496Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

N/A

denosumab

Rheumatoid Arthritis

N/A

Clinical Trials (1)

NCT01973569AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment

N/A

No Drug

Diabetic Peripheral Neuropathic Pain

N/A

Clinical Trials (1)

NCT06546202Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China

N/A

Trastuzumab deruxtecan

HER2-positive Breast Cancer

N/A

Clinical Trials (1)

NCT05458401EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan

N/A

Trastuzumab deruxtecan

HER2-positive Gastric Cancer

N/A

Clinical Trials (5)

NCT03523585DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Phase 3

NCT04704934Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

Lung Cancer

N/A

A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohisto

Cervical Cancers

N/A

Clinical Trials (1)

NCT06925113A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

N/A

Trastuzumab deruxtecan

Unresectable Breast Cancer

N/A

Clinical Trials (1)

NCT05945732DESTINY Breast Respond HER2-low Europe

N/A

IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care

Acute Stroke

N/A

ImplemeNtation oF demOnstration pRoject for Health systeMs: Atrial Fibrillation (INFORM-AF) Part 1

Atrial Fibrillation

N/A

Archival tissue specimen and immunohistochemistry staining

Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT05769764A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer

N/A

Aspirin

Impaired Glucose Tolerance

N/A

Clinical Trials (1)

NCT00122447Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance

N/A

Metastatic Breast Cancer in Austria

Breast Cancer

N/A

Colesevelam HCl

Diabetes Mellitus, Type 1

N/A

Colesevelam HCl

Type 2 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT00476710Effects of Colesevelam HCl On Bile Acid Kinetics

N/A

Bempedoic acid

Primary Hypercholesterolemiia

N/A

Clinical Trials (2)

NCT04579367Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

N/A

NCT06686615A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Non Interventional

Pseudoxanthoma Elasticum

N/A

Clinical Trials (1)

NCT05025722Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings

N/A

None

Breast Cancer

N/A

Clinical Trials (1)

NCT04807595Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

N/A

Exercise bout

Healthy

N/A

Clinical Trials (1)

NCT02565823The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue

N/A

not applicable

Ischemic Stroke

N/A

Edoxaban

Venous Thromboembolism

N/A

Clinical Trials (1)

NCT02952599Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)

N/A

CPT-11 based regimens

Metastatic Colorectal Cancer

N/A

Clinical Trials (1)

NCT01039506An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC)

N/A

Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology o

Oral Anticoagulants

N/A

CS-3150

Primary Aldosteronism

N/A

Clinical Trials (2)

NCT02890173Study of CS-3150 in Patients With Essential Hypertension

Phase 3

NCT02885662Study of CS-3150 in Patients With Primary Aldosteronism

N/A

Preventicus heartbeat app in combination with wearables

Atrial Arrhythmia

N/A

Clinical Trials (1)

NCT04579159The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)

N/A

Addressing Real-world Anticoagulant Management Issues in Stroke

Stroke

N/A

Exercise Intervention

Healthy

N/A

Clinical Trials (1)

NCT03037216Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans

N/A

Minimal documentation

Advanced Solid Tumor

N/A

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Rea

Breast Neoplasms

N/A

Clinical Trials (1)

NCT05573893PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

N/A

Edoxaban

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT02950168Edoxaban Management in Diagnostic and Therapeutic Procedures

N/A

Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding

Gastrointestinal Hemorrhage

N/A

mgt of bleeding concerns/complications of oral anticoagulants

Blood Coagulation